Evidone SA

History from 1 Feb 2024

Nominal capital · CHFCHF 113k

SHAB published 14 Feb 2024 · legal date 1 Feb 2024
Company formed
Founded 1 Feb 2024
SHAB HR01-1005961291 ↗
SHAB published 20 Apr 2026 · legal date 30 Mar 2026
Capital increase
Likely financing
Paid in cash
Nominal capital
100’000 → 113’333.33
Shares
— → 113’333’333
New shares, % of post-step shares
— (share counts not published)
Augmentation ordinaire du capital-actions. Nouveau capital-actions entièrement libéré: CHF 113'333.33, divisé en 113'333'333 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts. L'assemblée générale a introduit une clause statutaire relative à une marge de fluctuation du capital-actions par décision du 30.03.2026; pour les détails, voir les statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
- The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
- The company was founded less than six years before this capital increase.+0.5
- The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability
SHAB HR02-1006629918 ↗
SHAB published 20 Apr 2026 · legal date 30 Mar 2026
Capital band adopted
SHAB HR02-1006629918 ↗

Published by 26 Apr 2026

Record